期刊
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
卷 58, 期 1, 页码 58-67出版社
WILEY
DOI: 10.1002/bab.6
关键词
plant-made pharmaceuticals; plant biologic production; bioprocessing; clinical trials; biosimilars
The number of approaches to recombinant protein production in plants is greater than ever before. Development of these new and improved technologies as production platforms for plant-made pharmaceuticals has and will continue to create new commercial opportunities in the pharmaceutical sector. However, it is inevitable that no single system will be optimal for the production of all recombinant proteins of interest in plants due to both the physical characteristics and the envisaged therapeutic application of each product. Here, we review a range of promising product/platform pairs emphasizing synergies during production and in clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据